Incidence and Relative Risk of Peripheral Neuropathy in Cancer Patients Treated With Eribulin: A Meta-Analysis

Oncotarget - United States
doi 10.18632/oncotarget.21057
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

The Incidence and Relative Risk of Adverse Events in Patients Treated With Bisphosphonate Therapy for Breast Cancer: A Systematic Review and Meta-Analysis

Therapeutic Advances in Medical Oncology
Oncology
2019English

Incidence and Risk of Proteinuria With Aflibercept in Cancer Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Increased Risk of Cerebrovascular Events in Patients With Cancer Treated With Bevacizumab: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Lung Cancer Incidence in Patients With Schizophrenia: Meta-Analysis

British Journal of Psychiatry
MedicinePsychiatryMental Health
2019English

Incidence and Risk of Hematologic Toxicities in Cancer Patients Treated With Regorafenib

Oncotarget
Oncology
2017English

Correction: Incidence and Risk of Hematologic Toxicities in Cancer Patients Treated With Regorafenib

Oncotarget
Oncology
2019English

Incidence and Risk of Severe Neutropenia in Advanced Cancer Patients Treated With Cetuximab

Drugs in R and D
Pharmacology
2011English

Effects of Monochromatic Infrared Energy in Patients With Diabetic Peripheral Neuropathy: A Meta-Analysis of Randomized Clinical Trials

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Risk of Hepatotoxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Published Data

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy